Our understanding of the nature of the disordered carbohydrate metabolism in Addison's disease has advanced little since the original demonstration by Porges in 1910 (1) of the frequent occurrence of hypoglycemic reactions and the studies of Eppinger, Falta and Rudinger in which an increase in glucose tolerance was noted (2) .
Subsequently, however, it was shown that patients with Addison's disease developed marked symptoms of hypoglycemia following the administration of small doses of insulin (3) and failed to show a rise of blood sugar as great as normnal subjects following the injection of a standard dose of epinephrin (4) .
Recently Long, Katzin and Fry (5) reported in detail their studies relating to the effect of adrenal cortical hormone on the carbohydrate metabolism of experimental animals. From their own studies, as well as those of others, these authors concluded that " the administration of cortical extract apparently decreases the proportion of glucose oxidized while there is an increased proportion deposited as liver glycogen. . . . It is suggested that one of the properties of the cortical hormone is a stimulation of protein catabolism and that the increased carbohydrate levels, nitrogen and potassium excretion following its injection into animals is an expression of this effect."
A study of carbohydrate metabolism in untreated patients with Addison's disease is difficult because of the poor clinical condition of these patients. In the present study we have had the good fortune to be able to complete carefully controlled metabolic studies on a limited number of untreated patients and on a larger number of patients who were maintained in good condition by 2John D. Archbold, Fellow in Medicine. means of synthetic desoxycorticosterone acetate therapy.8
METHODS
Before these studies were undertaken, normal subjects and patients with Addison's disease were maintained for a period of 1 to 2 weeks on a standard diet of adequate caloric intake. The ratio of carbohydrate: protein: fat was kept constant. In most instances patients received 5 .0 grams of carbohydrate, 1.3 grams of protein and 1.5 grams of fat per kgm. of body weight.
Respiratory metabolism
During a preliminary period of 1 to 2 weeks, both the normal subjects and patients were trained for respiratory metabolic studies. Expired air was collected for 10-minute periods in a modified Baily gasometer and samples were analyzed in duplicate for carbon dioxide and oxygen by means of a Haldane-Henderson gas analyzer. Differential derivation of calories was made with the aid of Lusk's table (6) . In addition to determining the standard metabolism after a 15-hour fast, the respiratory metabolism, blood sugar (7) and urinary nitrogen (kjeldahl) were determined throughout the day at 2-hour intervals per cent solution in distilled water. The flow was adjusted so that the infusion was (Table I) . Oral glucose tolerance The striking intolerance of patients with Addison's disease to the oral administration of glucose is well known (11) . Not infrequently an adrenal crisis has been precepitated by this test.
A comparison between the blood glucose values of 8 control subjects and 4 untreated patients with Addison's disease following the oral administration of glucose, is shown in Figure 2 . The lownormal initial fasting sugar level, the " flat-type " of glucose curve, and the striking hypoglycemia which was frequently noted 2 to 3 hours following the administration of ministration of a standard dose of glucose (see Figure 5 ).
Following prolonged treatment (1 year or more) with desoxycorticosterone acetate, we observed a marked change in the oral glucose tolerance curve in 4 patients (Figure 3) . The Figure 5 ). In the patients with the "carbohydrate defect," three changes were of particular interest: (1) the ease with which hypoglycemia was precipitated; (2) the severity of the symptoms and the great difficulty which was experienced in spontaneously recovering from the induced hypoglycemia; and (3) Figure 7 . It is also of some interest to note that the injection of epinephrin during the hypoglycemic reaction precipitated by the standard intravenous glucose tolerance test was followed by a prompt but temporary rise in blood sugar level associated with a temporary remission in the hypoglycemic signs and symptoms (Figure 8 and more prolonged action of adrenal cortical hormone (4 to 24 hours).
In one patient the response to epinephrin following an overnight fast was observed in the untreated state and again after several days of treatment with adequate doses of adrenal cortical hormone (20 cc. daily, injected subcutaneously). Associated with treatment there was a small but definite increase in the height of the blood glucose curve, an increment of 27, 15, 11, 3 mgm., respectively, at 15, 30, 60 and 90 minutes following the subcutaneous injection of epinephrin (see methods).
Response to insulin Because of the profound reaction of patients with Addison's disease to relatively small doses of insulin, we did not study the action of this hormone in human subjects. In bilaterally adrenalectomized dogs (to be reported elsewhere), it was demonstrated that treatment (6 to 18 hours beforehand) with 50 to 80 cc. of adrenal cortical extract completely prevented the severe and often fatal hypoglycemic reaction which followed the intravenous injection of 0.25 units of insulin per kggm. Large quantities of desoxycorticosterone acetate (50 mgm. or more) were ineffective in preventing convulsions. Treatment with 17-hydroxy-11-dehydrocorticosterone, however, in a dose of 10 mgm., permitted the animal to survive the test without supplementary glucose therapy. The limited quantity of crystalline hormone available did not permit an exact determination of equivalent quantities of adrenal cortical extract and crystalline 17-hydroxy-1 1-dehydrocorticosterone.
Standard metabolism
The standard metabolism of patients with Addison's disease has been considered to be definitely lower than that of normal subjects. The values which were obtained in 15 untreated patients are given in Figure 9 . In our experience a basal PROT.O-5OGf glucose ( Figure 11 ). It is particularly significant that 48 hours after treatment with these substances had been discontined the standard respiratory quotient and the fasting blood glucose value had returned to the previous untreated level ( Figure  11 ). No ketonuria was observed during the short period of treatment with adrenal cortical extract, corticosterone or 17-hydroxy-11-dehydrocorticosterone. The possibility of ketonemia was not excluded.
In another type of experiment the effect of diet was observed on the standard respiratory quotient of normal subjects and patients with Addison's disease. An increase in the proportion of carbohydrate in the diet (protein and total calories being kept constant) resulted in a striking rise in the standard respiratory quotient of untreated patients with Addison's disease (Patient M. B., Figure 12 ) as well as in normal control subjects.
Respiratory quotient following the intravenous administration of glucose Because of the striking abnormality which was observed in the intravenous glucose curve of patients with Addison's disease, it seemed desirable to follow closely the changes in respiratory metabolism which occurred during this test. The respiratory quotient, total urinary nitrogen excretion and blood glucose values of 4 normal subjects and 5 patients with Addison's disease were followed during the standard intravenous glucose tolerance test (Table V) . The respiratory quotient rose to 0.90 or above in only one of the 4 normal subjects, whereas it exceeded 0.90 in all 5 of the patients with Addison's disease. Particularly noteworthy was the sudden and striking fall in respiratory quotient in Patients E. L., J. P., and M. B., as marked hypoglycemic symptoms be- Figure 13 ). Differential derivation of calories (Lusk's table) indicated that in the untreated state (Patient E. L., Figure 14 ) a high proportion of calories was derived from carbohydrate oxidation following the intravenous administration of glucose, particularly during the second hour of the test. During the third hour of the test, in the untreated patient, there was a sudden reduction in the proportion of calories derived from carbohydrate (low R/Q) immediately preceding the onset of marked symptoms of hypoglycemia. Treatment with desoxycorticosterone acetate had no effect on these changes. Treatment with adrenal cortical extract, 17-hydroxy-11-dehydrocorticosterone and corticosterone (in order of potency) was followed by a significant reduction in the proportion of Figure 6 ). Furthermore, it is significant that signs and symptoms of hypoglycemia did not become manifest during treatment with these substances although the blood glucose, on some occasions, was reduced to the level at which signs and symptoms had appeared in the untreated state.
Urinary nitrogen excretion
The rise in urinary nitrogen excretion which was observed during the standard intravenous glucose tolerance test was greater and more sustained in control subjects than in patients with Addison's disease (Table VI) . In Patient E. L.
( Figure 15 ), treatment with 17-hydroxy-11-dehydrocorticosterone and with adrenal cortical extract was followed by a striking rise in the urinary excretion of nitrogen during the intravenous glucose tolerance test. Treatment with desoxycorticosterone acetate was without effect, and treatment with corticosterone was followed by a change, intermediate between that of desoxycorticosterone acetate and 17-hydroxy-11-dehydrocorticosterone ( Figure 15 ). It is of interest to note that the greatest increases in urinary nitrogen excretion followed treatment with those adrenal cortical hormone preparations which had previously been shown to be the most potent in regulating carbohydrate metabolism. It is possible, however, that the changes in the renal excretion of nitrogen following hormone treatment may be due in part to changes in renal " function."
Prolonged fast Prolonged fasting was associated with a decrease in blood glucose, respiratory quotient and urinary nitrogen excretion (Patient M. B., Figure 16 ). Treatment with adrenal cortical extract was followed by a rise in blood glucose, a further decrease in respiratory quotient, and an increase in urinary nitrogen excretion.
It would appear that the efficacy of adrenal cortical hormone therapy in raising the blood glucose level during fasting was the result of increased glycogenesis without an equivalent increase in glucose utilization.
Necessity for adequate carbohydrate in diet Studies (M. B., Figure 12) 3. Hypoglycemia (55 mgrm.) was associated with a normal concentration of sodium and chloride in the blood with evidence of only slight hemoconcentration: serum sodium 140 m.eq., chloride 101.4 m.eq., and potassium 6.1 m.eq., per liter; carbon dioxide combining power 49 volumes per cent; non-protein nitrogen 27 mgm. per 100 cc. The urine contained acetone bodies 4 +.
The slightly higher-than-normal serum potassium value may be of some significance in association with the low blood glucose level (13) .
Thus within a period of 72 hours, during which he received a diet of adequate caloric content, and during a period in which blood pressure, plasma volume and electrolyte balance were maintained by means of desoxycorticosterone acetate treatment, this patient developed a severe hypoglycemic reaction. This study demonstrates the decreased glycogenesis which is associated with Addison's disease, as well as the inability of desoxycorticosterone acetate treatment to increase the formation of glucose from non-carbohydrate sources.
Hypoglycemia precipitated by intercurrent infections Acute respiratory infections and gastro-enteritis constitute the most frequent complications which precipitate hypoglycemia in patients with Addison's disease. If not recognized and treated this complication may result in a fatal outcome.
In the absence of complications, treatment with desoxycorticosterone acetate maintained a majority of patients with Addison's disease (12) in good clinical condition without supplementary treatment with specific carbohydrate-regulating factor. The frequent ingestion of food provided an adequate supply of readily available carbohydrate. However, when this source of supply was restricted (fasting, nausea, vomiting), or when the demand for carbohydrate was increased (fever, infection), the blood glucose level rapidly declined and severe hypoglycemic symptoms appeared despite adequate desoxycorticosterone acetate therapy. The reasons for the rapid onset of hypoglycemia in these patients appeared to be two-fold: (a) oxidation of carbohydrate which rapidly depleted available stores; and (b) inability to form adequate quantities of carbohydrate from nonglucose sources.
At present the only form of specific hormone therapy possessing carbohydrate-regulating factor which is available commercially is adrenal cortical extract. This must be used in large doses, 20 to 50 cc. daily, in the presence of severe infection. In addition, it is desirable to provide carbohydrate by parenteral administration of glucose solutions, if patients are unable to take adequate quantities of fruit juice, lactose, gingerale, etc., by mouth.
Lactic acid
Because of the position of lactic acid as a transition substance between protein and glycogen, and its importance in glucose oxidation, it seemed desirable to study its glycogenic action in patients with Addison's disease and in adrenalectomized animals.
In Patient 0. 0. treatment with lactic acid (18 grams of racemic lactic acid administered intravenously as the sodium salt dissolved in 1000 cc. of water) failed to alleviate the symptoms of hypoglycemia which were initiated by the standard intravenous glucose tolerance test. Glucose administered intravenously 1 hour after the lactate solution had been started promptly corrected the hypoglycemia. These observations on patients were confirmed by experiments on adrenalectomized dogs (14) in which d-lactic acid administered intravenously failed to prevent the convulsions induced by insulin, whereas treatment with glucose completely prevented signs of hypoglycemia. Direct evidence of the diminished ability of untreated adrenalectomized animals to convert lactic acid to glucose has also been obtained in phlorhizinized adrenalectomized rats (14) .
Physiological actizity of steroid compounds obtained from the adrenal cortex To date numerous crystalline compounds have been isolated from adrenal cortical extracts. In the present study we have compared the effect of three of these compounds on carbohydrate metabolism in man. Desoxycorticosterone, which appears to be the most active adrenal cortical compound thus far isolated as measured by its ability to maintain the life of adrenalectomized animals, is very potent in electrolyte-regulating property (9) . It appeared from this study that desoxycorticosterone treatment had little, if any, specific effect on carbohydrate metabolism in man. Corticosterone, a compound similar to desoxycorticosterone, but with an additional hydroxyl group, probably at C11, had less electrolyte-regulating property (15) than desoxycorticosterone, but it was much more potent in its carbohydrate-regulating effect. Seventeen-hydroxy-ll-dehydrocorticosterone was more potent in carbohydrate-regulating property than either corticosterone or desoxycorticosterone, but appeared from animal experiments to be much less effective than either of these compounds in regulating electrolyte balance and in maintaining the life of adrenalectomized animals. Thus oxygenation of desoxycorticosterone in positions 11 and 17 greatly increased carbohydrate-regulating potency but at the same time greatly decreased electrolyte-regulating and life-maintaining properties.
Potent adrenal cortical extracts appeared to contain appreciable quantities of both electrolyte and carbohydrate-regulating factors. However, in man, relatively large quantities of extract must be given to demonstrate either effect. Doctor E.
C. Kendall A comparison between the oral and intravenous glucose tolerance curves indicates that the socalled " flat-curve " following orally administered glucose actually represents delayed or poor absorption of glucose. Similar changes have been observed in a patient with idiopathic steatorrhea (non-tropical sprue). It appears from these studies that a " flat-curve " following orally administered glucose is of little diagnostic significance.
The striking hypoglycemia which occurs in many patients with Addison's disease following the standard intravenous glucose tolerance test is of great clinical significance since it implies the existence of a marked disturbance in carbohydrate metabolism. The test is of considerable aid in diagnosis, although it is not specific. Its greatest usefulness lies in the ease with which it permits a disturbance in carbohydrate metabolism to be detected. The changes which were observed in patients following intravenous glucose administration were in many ways similar to the changes observed by Kendall et al (13) in adrenalectomized dogs. A comparison between intravenous glucose tolerance curves performed before and after specific hormone therapy indicates that with adequate treatment there is a marked increase in the threshold at which severe hypoglycemic symptoms occur. Thus the adequately treated patient with Addison's disease and the normal subject frequently do not manifest symptoms at a blood glucose level which may be associated with marked signs and symptoms of hypoglycemia in the untreated patient. The exact mechanism for this difference in threshold is not known at present. Its clinical significance, however, is apparent.
The increase in fasting blood glucose level which was observed following the administration of crystalline corticosterone and 17-hydroxy-1 1-dehydrocorticosterone precludes the inference that a rise in blood glucose following adrenal cortical hormone therapy is necessarily due to contaminating substances, viz., epinephrin.
The increased height to which the blood glucose level rose, and the glycosuria which was observed following specific hormone therapy in Patient E. L. (Figure 6 ), substantiate the studies of Lukens (16) and others regarding the nature of the diabetes in patients with adrenal cortical hyperfunction (tumor and hyperplasia).
Preliminary studies on lactic acid metabolism indicate that the ability of patients with Addison's disease to form glucose from this substance is greatly impaired. These studies have -been confirmed experimentally in phlorhizinized rats and, in addition, it appears that the formation of glucose from pyruvate and from glycogenic amino acids is also impaired (14) . Treatment with potent adrenal cortical hormone restores to normal the capacity of these animals to form glucose from lactic acid, pyruvate and glycogenic amino acids.
It is suggested that in adrenal cortical insufficiency carbohydrate oxidation is adequate, although the ability to form glucose and glycogen from intermediate products of carbohydrate and protein metabolism is impaired. As a result, the glycogen depots in the body are soon exhausted, and ingested preformed carbohydrate is required to maintain the blood glucose level and to provide a readily available source of energy. Hormone therapy increases the ability of the body to form glucose and glycogen from the intermediate prod- 
